Corcept Therapeutics (CORT) FCF Margin (2012 - 2026)
Corcept Therapeutics' FCF Margin came in at 41.76% for Q3 2026, up 15.52 percentage points from 26.24% a year earlier and up 29.65 percentage points from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) FCF Margin (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Corcept Therapeutics reported FCF Margin of 20.20%, down 1.84 percentage points year-over-year; for FY2025, it came in at 18.62%, down 10.43 percentage points from FY2024.
- FCF Margin carries a five-year change of -23.97 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was 29.05% in FY2024 (+2.82 pp), 26.23% in FY2023 (-3.61 pp), 29.84% in FY2022 (-15.91 pp) and 45.75% in FY2021 (+3.15 pp).
- The Q3 2026 figure represents the highest quarterly FCF Margin since Q3 2023.
- Year-over-year, FCF Margin increased in two of the last eight quarters, with an average year-over-year change of -2.73 percentage points.
- The fastest year-over-year change in FCF Margin over five years came in Q4 2024 (a gain of 28.87 percentage points), and the weakest in Q2 2022 (a drop of 30.85 percentage points).
- Business Quant data shows CORT's FCF Margin at 12.11% (Q2 2026), -10.29% (Q1 2026) and 19.00% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 28.96% |
| 10 | Corcept Therapeutics | 7.99 Bn | 6.60 Bn | 335.86 Mn | 41.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 41.76% |
| Jun 30, 2026 | 12.11% |
| Mar 31, 2026 | -10.29% |
| Dec 31, 2025 | 19.00% |
| Sep 30, 2025 | 26.24% |
| Jun 30, 2025 | 22.75% |
| Mar 31, 2025 | 2.97% |
| Dec 31, 2024 | 32.95% |
| Sep 30, 2024 | 39.25% |
| Jun 30, 2024 | 24.89% |
| Mar 31, 2024 | 16.18% |
| Dec 31, 2023 | 4.08% |
| Sep 30, 2023 | 42.78% |
| Jun 30, 2023 | 35.84% |
| Mar 31, 2023 | 24.57% |
| Dec 31, 2022 | 32.37% |
| Sep 30, 2022 | 32.73% |
| Jun 30, 2022 | 17.43% |
| Mar 31, 2022 | 37.61% |
| Dec 31, 2021 | 49.95% |
API Access
Corcept Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();